Citation Impact
Citing Papers
Triple-Negative Breast Cancer
2010 Standout
Interferons and indoleamine 2,3-dioxygenase: Role in antimicrobial and antitumor effects
1989
Biological activities of sesquiterpene lactones
1986 Standout
L-Asparaginase and PEG Asparaginase— Past, Present, and Future
1993
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
2012 Standout
X chromosomal abnormalities in basal-like human breast cancer
2006
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Effect of pegylation on pharmaceuticals
2003 Standout
Long Noncoding RNAs in Cancer Pathways
2016 Standout
The substrate specificity of L‐asparaginase from Alcaligenes eutrophus
1971 StandoutNobel
Cardiac Glycosides as Novel Cancer Therapeutic Agents
2008 Standout
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
2003 Standout
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
2009 Standout
Pegaspargase: a review of clinical studies
2003
What made sesquiterpene lactones reach cancer clinical trials?
2010 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Structural and Functional Stabilization of L ‐Asparaginase via Multisubunit Immobilization onto Highly Activated Supports
2001
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases
2014 Standout
Designing hydrogels for controlled drug delivery
2016 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Amino acids and immune function
2007 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Protective effect of colchicine on acute liver damage induced by CCL4. Role of cytochrome p‐450
1995
Natural compounds for cancer treatment and prevention
2009 Standout
PEGylation, successful approach to drug delivery
2005 Standout
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers
2016 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
2018 StandoutNobel
The disappearing Barr body in breast and ovarian cancers
2007
E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children
1970
Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
1993 Standout
Production of l -Asparaginase II by Escherichia coli
1968
Purification and properties of asparaginase from Escherichia coli B
1969
Regulation of glutaminase levels in Escherichia coli
1975 StandoutNobel
L-Asparaginase and Human Malignant Disease
1971 Nature
Antineoplastic Principles in Plants: Recent Developments in the Field
1970
Crystallographic Evidence for the Tetrameric Subunit Structure of l ‐Asparaginase from Escherichia coli
1971 StandoutNobel
Toxicity of E. coli L-asparaginase in man
1970
Clinical evaluation of l-asparaginase.Introduction
1970
The Inhibition of Lymphocyte Blastogenesis By L-Asparaginase
1970
Improvement of enzyme activity, stability and selectivity via immobilization techniques
2007 Standout
Elevated urinary total sialic acid and increased oxidative stress in patients with bladder cancer
2010
Biological activities of sesquiterpene lactones
1976 Standout
Sialic acid as a tumor marker.
1994
Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis
2016 StandoutNobel
FDA-approved poly(ethylene glycol)–protein conjugate drugs
2011
Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors
1970
Patients with a high jejunostomy do not need a special diet
1986
Heme-Containing Oxygenases
1996 Standout
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
2006
Insolubilization of L-asparaginase by covalent attachment to nylon tubing
1972 StandoutNobel
Synthesis and Biological Activity of α‐Methylene‐γ‐butyrolactones
1985 Standout
Fatty liver: Biochemical and clinical considerations
1975
Works of Schwartz Mk being referenced
Plasma lipid bound sialic acid in patients with prostate and bladder cancer.
1981
Lipid-bound sialic acid as a tumor marker.
1983
Fat and nitrogen metabolism in patients with massive small bowel resections.
1956
Alkaline and acid phosphatases.
1961
Inhibition of leukemias in man by L-asparaginase.
1967
Barr body distribution and estrogen receptor protein in mammary carcinoma.
1978